These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 2035004)

  • 1. [Advantages and drawbacks of human insulin].
    Zenobi PD
    Schweiz Med Wochenschr; 1991 Apr; 121(14):475-81. PubMed ID: 2035004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The place of "monocomponent" insulins in diabetes mellitus therapy].
    Teuscher A
    Schweiz Med Wochenschr; 1975 Apr; 105(16):485-94. PubMed ID: 1215860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [HLA typing and insulin antibody production in insulin-dependent diabetics].
    Bruni B; Barolo P; Gadaleta G; Gamba Ansaldi S; Grassi G; Zerbinati A; Molinatti M; Salvetti E
    Ann Osp Maria Vittoria Torino; 1984; 27(7-12):185-213. PubMed ID: 6443704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parental preference of prandial insulin aspart compared with preprandial human insulin in a basal-bolus scheme with NPH insulin in a 12-wk crossover study of preschool children with type 1 diabetes.
    Danne T; Råstam J; Odendahl R; Näke A; Schimmel U; Szczepanski R; Moeller J; Deiss D
    Pediatr Diabetes; 2007 Oct; 8(5):278-85. PubMed ID: 17850471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Monocomponent insulin: general considerations].
    Rodriguez-Miñon JL; Rios MS
    Journ Annu Diabetol Hotel Dieu; 1978; ():109-22. PubMed ID: 651088
    [No Abstract]   [Full Text] [Related]  

  • 6. [Long-term clinical results with monocomponent insulin (MC lente) in infantile and juvenile diabetes].
    Bruni KB; Neirotti R; Albonico G; Gamba S; Regis G; D'Adda A; Soldano E; Bruni B
    Ann Osp Maria Vittoria Torino; 1976; 19(16):7-26. PubMed ID: 1027349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Insulin lipoatrophy and its elimination through the use of monocomponent insulin].
    Maaz E
    Z Gesamte Inn Med; 1976 Nov; 31(22):941-5. PubMed ID: 1035452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of juvenile diabetes mellitus.
    Chaney C; Elders MJ
    J Ark Med Soc; 1975 Aug; 72(3):111-27. PubMed ID: 125737
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypoglycemia: the price of intensive insulin therapy for pregnant women with insulin-dependent diabetes mellitus.
    Rosenn BM; Miodovnik M; Holcberg G; Khoury JC; Siddiqi TA
    Obstet Gynecol; 1995 Mar; 85(3):417-22. PubMed ID: 7862383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin lispro: new preparation. Faster acting.
    Prescrire Int; 1998 Jun; 7(35):67-8. PubMed ID: 10342918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Observational, open-label study of type 1 and type 2 diabetes patients switching from human insulin to insulin analogue basal-bolus regimens: insights from the PREDICTIVE study.
    Hermansen K; Dornhorst A; Sreenan S
    Curr Med Res Opin; 2009 Nov; 25(11):2601-8. PubMed ID: 19739940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Insulin therapy].
    Petrides P
    Munch Med Wochenschr; 1970 Jul; 112(27):1273-7. PubMed ID: 4246479
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of human insulin on antibody formation in pregnant diabetics and their newborns.
    Chertow BS; Baranetsky NG; Sivitz WI; Swain PA; Grey J; Charles D
    Obstet Gynecol; 1988 Nov; 72(5):724-8. PubMed ID: 3050653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does insulin administration contribute to immune complex formation in diabetes?
    Campbell LV; Charlesworth JA; Pasterfield GV; Jenkins A; Pussell BA
    Clin Exp Immunol; 1984 Nov; 58(2):255-63. PubMed ID: 6388921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duration of type I diabetes affects glucagon and glucose responses to insulin-induced hypoglycemia.
    Lorenzi M; Bohannon N; Tsalikian E; Karam JH
    West J Med; 1984 Oct; 141(4):467-71. PubMed ID: 6390972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoglycemia in type 1 diabetes: a still unresolved problem in the era of insulin analogs and pump therapy.
    Shalitin S; Phillip M
    Diabetes Care; 2008 Feb; 31 Suppl 2():S121-4. PubMed ID: 18227471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factors I and II peptide and messenger RNA levels in macrosomic infants of diabetic pregnancies.
    Roth S; Abernathy MP; Lee WH; Pratt L; Denne S; Golichowski A; Pescovitz OH
    J Soc Gynecol Investig; 1996; 3(2):78-84. PubMed ID: 8796812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extreme insulin resistance: a consequence of insulin switching?
    Keenan WF; Abgott MA
    J Fam Pract; 1988 Dec; 27(6):635-6. PubMed ID: 3058859
    [No Abstract]   [Full Text] [Related]  

  • 19. Lipoatrophy secondary to human insulin treatment. Immunological study.
    Igea JM; Escalada J; Cuevas M; Sainz T; Barrio R
    Allergol Immunopathol (Madr); 1992; 20(4):173-5. PubMed ID: 1485599
    [No Abstract]   [Full Text] [Related]  

  • 20. Insulin antibody response to a short course of human insulin therapy in women with gestational diabetes.
    Balsells M; Corcoy R; Mauricio D; Morales J; García-Patterson A; Carreras G; Puig-Domingo M; de Leiva A
    Diabetes Care; 1997 Jul; 20(7):1172-5. PubMed ID: 9203458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.